A randomized, double-blind, placebo-controlled, phase IIIb trial (ATLAS) comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy with B for first-line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC)

V.A. Miller, Arabinda K. Das, M. Rossi

Journal of Clinical Oncology

Cancer ManagementPathologyFirst-line TreatmentPharmacotherapyMay 30 +17

Laparoscopic Technique for Performing Duodenal Switch with Gastric Reduction

Robert A. Rabkin, John M. Rabkin, Barbara Metcalf, +3

Obesity Surgery

LaparoscopySleeve GastrectomyGastroenterologySurgeryUpper Gastrointestinal Surgery +2

A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors

Aaron S. Mansfield, David S. Hong, Christine L. Hann, +17

npj Precision Oncology

Nutritional Markers following Duodenal Switch for Morbid Obesity

Robert A. Rabkin, John M. Rabkin, Barbara Metcalf, +3

Obesity Surgery

MalnutritionNutritionObesityPhysiologyClinical Nutrition +5

Detection of common bile duct stones before laparoscopic cholecystectomy. Evaluation with MR cholangiography

Piero Boraschi, R Gigoni, Giulia Braccini, +3

Acta Radiologica

SC-002 in patients with relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma: Phase 1 study

Daniel Morgensztern, Melissa L. Johnson, Charles M. Rudin, +4

Lung Cancer

Endocrine OncologyMedicinePathologyBronchial NeoplasmCancer Treatment +4

Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study

Erika Hamilton, David M. O’Malley, Roisin E. O’Cearbhaill, +8

Gynecologic Oncology

Platinum-resistant/refractory Ovarian CancerMedicineCancer ManagementPharmacologyTamrintamab Pamozirine +7

Malignant obstructive jaundice: comparison of MRCP and ERCP in the evaluation of distal lesions.

Ernesto Di Cesare, Edoardo Puglielli, O Michelini, +3

PubMed

Laparoscopic versus open cholecystectomy. An analysis of clinical and financial aspects.

Mario Schietroma, Francesco Carlei, Charalampos I. Liakos, +4

PubMed

The value of electrochemotherapy in the treatment of peristomal tumors

L Campana, Giulia Bertino, Carlo Riccardo Rossi, +4

European Journal of Surgical Oncology

Surgical OncologyPeristomal TumorsMedicineSurgical PathologySurgery +3